proportional to the number of small, dynamic adhesions within the cell. The data from Gupton and Waterman-Storer (2006) suggest that low fibronectin is suboptimal for migration because there are too few adhesions even though the adhesions are dynamic. High fibronectin is suboptimal because the adhesions are too stable and do not signal. Cells on intermediate fibronectin have a high number of small, dynamic adhesions of the kind that are known to signal to Rac and Cdc42. Thus, the overall rates of both integrin ligation and adhesion assembly should be maximal, leading to high Rac and Cdc42 activity. These simple dynamics may be the key factor driving lamellipodial actin polymerization and flow.
The differential effects on Rho activity can also be understood if we consider integrin activation of Rho, which is temporally biphasic (Ren et al., 1999) . Following new integrin ligation, Rho activity first decreases, followed by an increase at later times. Thus, young adhesions appear to inhibit Rho, whereas more mature adhesions activate it. As adhesion lifetimes increase in direct proportion to the concentration of fibronectin, these results may explain why Rho activity correlates with fibronectin.
This study has revealed some major insights and represents a large step in our understanding of cell migration. However, there are more chapters to be written. The actinintegrin linkage is a critical site that integrates adhesion, signaling, and protrusion; its regulation remains to be parsed. The "clutch" mechanisms by which myosin II-mediated tension regulates both adhesion assembly and disassembly may depend on the state of the adhesion, which remains to be defined. Finally, some highly motile cells do not show the highly organized adhesions and actin filaments seen in fibroblasts or epithelial cells migrating on fibronectin yet can show optima in migration speed that are dependent on substrate concentration. The factors that produce this relationship in these cells remain to be established. Higher eukaryotes invest considerable capital in carefully regulating thousands of genes. These genes are not only expressed at the correct time, place, and level, but many of these genes must respond rapidly and specifically to multiple developmental, nutritional, and environmental signals. To this end, sophisticated mechanisms of transcriptional regulation have evolved. One major class of factors that provides the selectivity of a gene's transcriptional regulation is sequence-specific DNA binding transcription factors. These in Hormones trigger dramatic changes in the structure and transcriptional activity of specific promoters that lead to exchange of repression complexes for activation complexes. Ju et al. (2006) now show that estrogen-dependent restructuring and transcription of the pS2 promoter require the generation of a DNA double-strand break by a novel protein complex containing two enzymes, topoisomerase IIβ and poly(ADP-ribose) polymerase.
turn bind to a diverse set of coregulators that can recruit RNA polymerase II (Pol II) or modify chromatin to promote or inhibit transcription. In a recent paper in Science, Ju et al. (2006) add a new and interesting dimension to signal-regulated gene activation in their studies of the estrogen-responsive pS2 gene. They show that estrogen-dependent transcription of pS2 requires a promoter intermediate containing a doublestrand break (DSB). In addition, they demonstrate that the DSB is generated by a protein complex containing two enzymes, topoisomerase II (TopoIIβ) and poly(ADP-ribose) polymerase (PARP-1), each of which is required for transcription activation and participates in a variety of other nuclear processes (Figure 1) .
TopoII is an enzyme with double-strand cleavage and ligation activities that catalyzes topological changes by allowing the passage of one DNA helix through another. TopoII is involved in several nuclear functions, including chromosome segregation, chromosome condensation, DNA replication, genome stability, and chromosome organization (Austin and Marsh, 1998) . The TopoII activity in vertebrates is encoded by two distinct genes, α and β. TopoIIα appears to be required for chromosome condensation and segregation, whereas the role of TopoIIβ is less well understood (Austin and Marsh, 1998 ). TopoII's function in transcription and its regulation have been a subject of speculation and investigation for decades, in part because TopoII's ability to create a DSB in DNA provides a means of resolving topological barriers, such as the supercoiling induced during transcription and other chromosomal processes. In this regard, previous studies have mapped TopoII cleavage sites to the 5′ ends of some genes and localized the distinct, but related, enzyme TopoI to actively transcribed regions (Kroeger and Rowe, 1992) .
PARP-1, the most abundantly expressed member of a family of PARP proteins, catalyzes the polymerization of ADP-ribose units from donor NAD + molecules on target proteins . PARP-1 and the poly(ADP-ribosyl)ation of proteins are involved in DNA repair, cell death, mitotic apparatus function, chromatin regulation, and transcription regulation . In addition to its catalytic activity, PARP-1 also binds to DNA through its double zinc finger DNA binding domain.
PARP-1 has low basal enzymatic activity that is allosterically stimulated by single-and double-strand DNA breaks, protein binding partners, and nucleosomes, providing a mechanism for the regulation of PARP-1-dependent functions. The targets of PARP-1 enzymatic activity include a variety of nuclear proteins, including PARP-1 itself and histones, such as the linker histone H1. Recent studies have suggested a role for PARP-1 in the regulation of chromatin structure and transcription (Ju et al., 2004; Kim et al., 2004; Pavri et al., 2005; Tulin and Spradling, 2003) . For example, PARP-1 functions as a nucleosome binding factor that can regulate the extent of chromatin compaction. In addition, PARP-1 acts as a promoter-specific exchange factor that promotes the binding and release of components of the transcriptional machinery. PARP-1 has numerous other protein partners in the cell and functions in a variety of other cellular processes as well . Ju et al. (2006) now show that TopoIIβ and PARP-1 collaborate in an interesting way that alters the molecular composition and structure of the pS2 promoter during an estradiol (E2)-dependent transcriptional response. A previously identified PARP-1 corepressor complex-containing nucleolin, nucleophosmin, and Hsp70 (Ju et al., 2004 )-as well as the N-CoR and HDAC3 corepressors are associated with the repressed promoter. E2 not only rapidly induces (within 10 min) an increase in binding of estrogen receptor α (ERα) to the promoter but also causes a concomitant rapid exchange of the corepressors for what appears to be an activation complex containing PARP-1 and TopoIIβ. Interestingly, the activation complex also contains Ku86/70 and DNA-PK, factors, which are normally associated with DNA damage and repair. At later times (30 min after treatment with E2), the acetyltransferase CBP and Pol II are recruited to the promoter to complete the activation process. Shown is a timecourse depicting changes-DNA cleavage and the exchange of factors-at the pS2 promoter centered on the estrogen response element (ERE) following estradiol treatment, which causes transcription activation. This figure is based on data and a model presented in Ju et al. (2006) . In most cases, binding of factors to the individual nucleosomes (NucU, NucE, and NucT) was assayed, whereas in some cases, the entire region encompassing all three nucleosomes was assayed (indicated by brackets). For PARP-1 and H1, weaker association is indicated by a dotted outline of these factors. The TopoIIβ complex shown at the 10 min and 30 min time points also contains DNAPK, Ku86, and Ku70. The ERα shown represents a homodimer.
Interestingly, both PARP-1 and TopoIIβ enzymatic activities are critical for the activation of pS2 transcription. Ju et al. (2006) show that chemical inhibitors of PARP-1, or microinjection of either PARP-1 antibody or siRNA, inhibited ERα-dependent gene activation. Restoration of siRNA-mediated PARP-1 knockdown required introduction of catalytically competent PARP-1. The definitive target of this PARP-1 enzymatic activity has yet to be determined, although PARP-1 itself, H1, and TopoII can be poly(ADPribosyl)ated and are thus candidates (Darby et al., 1985; Kim et al., 2004) . In addition, Ju et al. (2006) used a specific TopoII inhibitor as well as transfection experiments with a TopoIIβ catalytic mutant to show that TopoII activity is required for the E2-dependent activation of pS2. What does the TopoIIβ enzymatic activity do? Ju et al. (2006) developed a sensitive method to demonstrate that a transient DSB occurs in promoter DNA adjacent to a nucleosome containing the DNA binding sequence for ERα ("NucE"). The formation of this DSB requires TopoIIβ enzymatic activity and participates in the subsequent exchange of factors at the promoter. A possible role for the TopoIIβ-dependent DSB in stimulating PARP-1 enzymatic activity has yet to be addressed.
In an elegant next step, Ju et al. (2006) examined the changes in factor occupancy at the pS2 promoter by chromatin immunoprecipitation at the level of individual nucleosomes. They found that, prior to treatment with E2, PARP-1 is associated with three adjacent nucleosomes in the promoter region (NucE and a nucleosome on each side, NucU and NucT), possibly acting as part of a repression complex (Ju et al., 2004) or as a direct nucleosome binding factor (Kim et al., 2004) (Figure 1 ). Upon estrogen treatment, PARP-1 departs from NucU and NucT, perhaps as a consequence of auto poly(ADPribosyl)ation, resulting in a loss of nucleosome binding activity (Kim et al., 2004) . In addition, a PARP-1/TopoIIβ activation complex containing the nuclear receptor coactivator ASC2 becomes concentrated on NucE. The factor dynamics on the three nucleosomes are accompanied by changes in chromatin structure. H1 is lost from NucE and is replaced with HMGB1/2, a nonhistone structural protein. The authors suggest that H1 could be a target for poly(ADP-ribosyl)ation by PARP-1, causing its release. Alternatively, PARP-1's ability to compete with H1 for binding to nucleosomes could function in the dissociation of H1 from NucE (Kim et al., 2004) .
The importance of the TopoIIβ-dependent double-strand cleavage of the DNA upstream of NucE is most evident in the context of the exchange of factors at the pS2 promoter. In this regard, Ju et al. (2006) showed that the changes in DNA and chromatin structure, as well as the subsequent recruitment of the CBP coactivator and Pol II, are inhibited by merbarone, a TopoII inhibitor. What mechanistic role might the transient DSB at the promoter have? One could imagine that this cleavage resolves a topological barrier allowing a critical structural change in the promoter. The specific role of DSB and the details of the mechanistic interplay between TopoIIβ and PARP-1 remain an important issue to resolve.
The generality of the observed pS2 promoter cleavage following gene activation is an intriguing issue. Past studies have identified TopoII cleavage sites associated with hypersensitive sites in promoter regions of uninduced Drosophila hsp70 and constitutively active actin-5C genes (Kroeger and Rowe, 1992) . In addition to pS2, Ju et al. (2006) observed recruitment of TopoIIβ and PARP-1 and other components of the complex to the PSA, RARβ, Dio1, and MMP12 promoters upon gene activation, as well as promoter cleavage. The promoter cleavage relative to the adjacent upstream and coding regions was not reported, but the enhanced cleavage of active compared to inactive promoters was clear. Future studies including genome-wide analyses would reveal if TopoIIβ promoter cleavage is broadly associated with gene activation. Such broad mapping studies would need to be interpreted cautiously because nuclease hypersensitive regions associated with active or primed promoters could be fortuitous targets of TopoIIβ cleavage. To demonstrate that cleavage is a prerequisite of activation will require more thorough studies like those done by Ju et al. (2006) for the pS2 promoter. Additionally, one should keep in mind that promoters come in many "flavors." Many are primed for activation and have promoters occupied by basal transcription factors and transcriptionally paused Pol II (Lis, 1998) . It will be of interest to see how many distinct classes of promoters require a specific DSB and at what stage cleavage plays a role in priming and activation.
